INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
03/27/2026
Back to search
Official data from USPTO
SAH SWISS ALP HEALTH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
53
Latest update
03/28/2026
Trademark type
Combined
Nice classes
5
Filing date
07/03/2013
Registration date
08/19/2014
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/30/2025
Last transaction
03/28/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
Belmont-Lausanne, CH
Examiner
MACIOL II, EUGENE VALENTINE-JO
Current location
Historical data usage
Mark description
The mark consists of the wording "SWISS ALP HEALTH" below a shaded circle with the letters "SAH" appearing inside with decorative hearts and scroll designs appearing around the circle.
Holders and representatives
Holders
S. S. (pessoa física)
R. B. (pessoa física)
Representatives
James R Menker Holley & Menker, PA
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and veterinary preparations and substances for the preventiontreatment and alleviation of disordersdiseasesconditions and ailments of the central nervous system; pharmaceutical preparations and substances for the preventiontreatment and alleviation of depression; pharmaceutical preparations and substances for the preventiontreatment and alleviation of sleep disordersstress and anxietyherbal pharmaceutical preparations; pharmaceutical and veterinary preparations and substances for the preventiontreatment and alleviation of disordersdiseasesconditions and ailments of the cardio-vascular system; pharmaceutical and veterinary preparations and substances for the preventiontreatment and alleviation of disordersdiseasesconditions and ailments of the respiratory system; pharmaceutical and veterinary preparations and substances for the preventiontreatment and alleviation of disordersdiseasesconditions and ailments of the immune system; pharmaceutical and veterinary preparations and substances for the preventiontreatment and alleviation of disordersdiseasesconditions and ailments of the musculo-skeletal systembone and connective tissue diseases and bone and cartilage degenerative conditions; Chondroitin preparations for human and veterinary use; pharmaceutical and veterinary preparations and substances for the preventiontreatment and alleviation of pain and inflammationsystemic and topical pain relief medication and anti-inflammatories; pharmaceutical preparations and substancesmedicated skin care preparations for use in dermatologydermatitis and skin pigmentation diseases; pharmaceutical preparations and substances for use in ophthalmologyophthalmic preparations and ophthalmologic preparations; pharmaceutical preparations and substances for the preventiontreatment and alleviation of menopausecirculatoryneurologicdigestiveauto-immunepulmonarymusculoskeletalgastrointestinalskeletalviralurinaryrenalinfectiousmetabolic diseasesillnessesdisorders or conditions; sanitary preparations for medical use; dietetic food and substances for medical or veterinary usedietary and nutritional supplements in liquidpowder or solid formsamino acids for nutritional purposespowdered nutritional supplement concentratevitamin preparationsvitamin and mineral preparations for medical useherbal supplementsmedicinal herb extractsprotein supplementsnutritional supplements in the nature of carbohydrates in liquidpowder or solid formsdietary fiber to aid digestionmedicated creams and lotions for dermatological use; food for babies ; food supplements for humans and animals; medical plasters; medical dressings; herbicides; all the aforesaid goods of Swiss origin
Publications
History of USPTO decisions and trademark events.
53 publications found
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
09/30/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
01/30/2025
71AG
REGISTERED-SEC.71 ACCEPTED
01/30/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/28/2025
ES71
TEAS SECTION 71 RECEIVED
07/25/2024
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
08/19/2023
RNWL
INTERNATIONAL REGISTRATION RENEWED
07/14/2023
NA15
SEC. 15 ACKNOWLEDGEMENT - E-MAILED
06/25/2021
15AK
REGISTERED - SEC. 15 ACKNOWLEDGED
06/25/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/25/2021
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
06/20/2021
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
05/06/2021
INPC
INVALIDATION PROCESSED
05/06/2021
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
05/01/2021
E15R
TEAS SECTION 15 RECEIVED
01/01/2021
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
09/01/2020
71AG
REGISTERED-SEC.71 ACCEPTED
09/01/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/31/2020
ES71
TEAS SECTION 71 RECEIVED
08/12/2020
CHLD
CHANGE OF OWNER RECEIVED FROM IB
03/01/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/23/2015
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/10/2014
FIMP
FINAL DISPOSITION PROCESSED
12/10/2014
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/19/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
08/19/2014
PUBO
PUBLISHED FOR OPPOSITION
06/03/2014
GPNX
NOTIFICATION PROCESSED BY IB
05/30/2014
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/22/2014
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/14/2014
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/14/2014
NPUB
NOTICE OF PUBLICATION
05/14/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/25/2014
ALIE
ASSIGNED TO LIE
04/23/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/01/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/13/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/13/2014
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/13/2014
CNFR
FINAL REFUSAL MAILED
03/11/2014
CNFR
FINAL REFUSAL WRITTEN
03/10/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/14/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/13/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/13/2014
RFNT
REFUSAL PROCESSED BY IB
11/16/2013
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/28/2013
RFRR
REFUSAL PROCESSED BY MPU
10/25/2013
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/24/2013
CNRT
NON-FINAL ACTION WRITTEN
10/23/2013
DOCK
ASSIGNED TO EXAMINER
10/16/2013
MAFR
APPLICATION FILING RECEIPT MAILED
09/27/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/23/2013
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
09/20/2013
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/19/2013
Continuous trademark protection
Get notified about every new filing that threatens SAH SWISS ALP HEALTH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.